Motomiya, Yoshihiro, et al. “Serum Levels of the C-Terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients With Hemodialysis Undergoing Treatment With a Proline Hydroxylase Domain (PHD) Inhibitor”. Journal of Clinical Nephrology, vol. 8, no. 3, Oct. 2024, pp. 132-7, doi:10.29328/journal.jcn.1001141.